• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗心磷脂抗体识别的β2-糖蛋白I上的表位。

Epitopes on beta2-GPI recognized by anticardiolipin antibodies.

作者信息

Koike T, Ichikawa K, Kasahara H, Atsumi T, Tsutsumi A, Matsuura E

机构信息

Department of Medicine II, Hokkaido University School of Medicine, Sapporo, Japan.

出版信息

Lupus. 1998;7 Suppl 2:S14-7. doi: 10.1177/096120339800700204.

DOI:10.1177/096120339800700204
PMID:9814665
Abstract

Anticardiolipin antibodies (aCL) found in sera from patients with antiphospholipid syndrome recognize a cryptic epitope that appears on the beta2-glycoprotein I (beta2-GPI) molecule when beta2-GPI interacts with a lipid membrane composed of negatively charged phospholipid or when beta2-GPI is adsorbed on a polyoxygenated polystyrene plate. A homology based model of beta2-GPI was constructed based on the NMR coordinates of sushi domains of human factor H. The conformation was like a cylinder consisting of five domains, its IV and V domains being glued by electrostatic interaction. We used phage-displayed random peptide libraries to search the epitopes of human aCL. Structures similar to consensus sequences selected by a biopanning method was found on domain IV of beta2-GPI.

摘要

抗磷脂综合征患者血清中发现的抗心磷脂抗体(aCL)识别一种隐蔽表位,当β2-糖蛋白I(β2-GPI)与由带负电荷磷脂组成的脂质膜相互作用时,或当β2-GPI吸附在多氧化聚苯乙烯板上时,该表位出现在β2-GPI分子上。基于人因子H的寿司结构域的核磁共振坐标构建了β2-GPI的同源模型。其构象像一个由五个结构域组成的圆柱体,其四结构域和五结构域通过静电相互作用结合在一起。我们使用噬菌体展示随机肽库来搜索人aCL的表位。在β2-GPI的四结构域上发现了与通过生物淘选方法选择的共有序列相似的结构。

相似文献

1
Epitopes on beta2-GPI recognized by anticardiolipin antibodies.抗心磷脂抗体识别的β2-糖蛋白I上的表位。
Lupus. 1998;7 Suppl 2:S14-7. doi: 10.1177/096120339800700204.
2
Antiphospholipid antibodies and atherosclerosis.
Lupus. 1998;7 Suppl 2:S135-9. doi: 10.1177/096120339800700230.
3
A chemically defined, toleragen-based approach for targeting anti-beta2-glycoprotein I antibodies.一种针对抗β2糖蛋白I抗体的基于耐受性原的化学定义方法。
Lupus. 1998;7 Suppl 2:S166-9. doi: 10.1177/096120339800700236.
4
Antigenic structures recognized by anti-beta2-glycoprotein I auto-antibodies.抗β2糖蛋白I自身抗体识别的抗原结构。
Int Immunol. 2005 Dec;17(12):1533-42. doi: 10.1093/intimm/dxh330. Epub 2005 Oct 12.
5
Beta2-glycoprotein I: target antigen for 'antiphospholipid' antibodies. Immunological and molecular aspects.β2-糖蛋白I:“抗磷脂”抗体的靶抗原。免疫学及分子学方面
Lupus. 1998;7 Suppl 2:S5-9. doi: 10.1177/096120339800700202.
6
Molecular studies on phospholipid-binding sites and cryptic epitopes appearing on beta 2-glycoprotein I structure recognized by anticardiolipin antibodies.关于抗心磷脂抗体识别的β2-糖蛋白I结构上出现的磷脂结合位点和隐蔽表位的分子研究。
Lupus. 1995 Feb;4 Suppl 1:S13-7. doi: 10.1177/096120339400400104.
7
Binding of anticardiolipin antibodies to protein C via beta2-glycoprotein I (beta2-GPI): a possible mechanism in the inhibitory effect of antiphospholipid antibodies on the protein C system.抗心磷脂抗体通过β2-糖蛋白I(β2-GPI)与蛋白C结合:抗磷脂抗体对蛋白C系统产生抑制作用的一种可能机制。
Clin Exp Immunol. 1998 May;112(2):325-33. doi: 10.1046/j.1365-2249.1998.00582.x.
8
IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.对于临床怀疑抗磷脂抗体综合征的患者,与磷脂结合的β2糖蛋白I的IgG反应性是通过添加六方(II)相磷脂淬灭的狼疮抗凝活性部分的主要决定因素。
Haematologica. 1999 Sep;84(9):829-38.
9
Epitope specificity of monoclonal anti-beta 2-glycoprotein I antibodies derived from patients with the antiphospholipid syndrome.抗磷脂综合征患者来源的单克隆抗β2-糖蛋白I抗体的表位特异性
J Immunol. 1995 Aug 1;155(3):1629-36.
10
beta 2-Glycoprotein I reactivity of monoclonal anticardiolipin antibodies from patients with the antiphospholipid syndrome.抗磷脂综合征患者单克隆抗心磷脂抗体的β2-糖蛋白I反应性
Arthritis Rheum. 1994 Oct;37(10):1453-61. doi: 10.1002/art.1780371008.

引用本文的文献

1
Molecular Mechanisms of "Antiphospholipid Antibodies" and Their Paradoxical Role in the Pathogenesis of "Seronegative APS".“抗磷脂抗体”的分子机制及其在“血清阴性 APS”发病机制中的矛盾作用。
Int J Mol Sci. 2020 Nov 9;21(21):8411. doi: 10.3390/ijms21218411.
2
βGP1, Anti-βGP1 Antibodies and Platelets: Key Players in the Antiphospholipid Syndrome.β糖蛋白1、抗β糖蛋白1抗体与血小板:抗磷脂综合征中的关键因素
Antibodies (Basel). 2016 May 6;5(2):12. doi: 10.3390/antib5020012.
3
New tests to detect antiphospholipid antibodies: anti-domain I beta-2-glycoprotein-I antibodies.
新型抗磷脂抗体检测方法:抗结构域 I 型β-2-糖蛋白 I 抗体。
Curr Rheumatol Rep. 2014 Feb;16(2):402. doi: 10.1007/s11926-013-0402-7.
4
Pharmacokinetics of LJP 993, a tetrameric conjugate of domain 1 of beta2-glycoprotein I for antiphospholipid syndrome.抗磷脂综合征β2-糖蛋白 I 结构域 1 四聚体缀合物 LJP 993 的药代动力学。
Lupus. 2010 Feb;19(2):130-7. doi: 10.1177/0961203309348982. Epub 2009 Nov 17.
5
Pentraxins, anti-pentraxin antibodies, and atherosclerosis.五聚体蛋白、抗五聚体蛋白抗体与动脉粥样硬化
Clin Rev Allergy Immunol. 2009 Aug;37(1):36-43. doi: 10.1007/s12016-008-8098-6.